US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Insight Molecular Diagnostics Inc.

4.33

-0.0100-0.23%

Volume:21.13K

Turnover:91.04K

Market Cap:141.70M

PE:-2.96

High:4.46

Open:4.37

Low:4.23

Close:4.34

52wk High:8.51

52wk Low:2.33

Shares:32.72M

Float Shares:10.41M

Volume Ratio:0.42

T/O Rate:0.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.4638

EPS(LYR):-1.6500

ROE:-23603.11%

ROA:-57.82%

PB:-6.65

PE(LYR):-2.62

Loading ...

Overview Company News Filings

Insight Molecular Diagnostics initiated with a Buy at Lucid Capital

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), Insight Molecular Diagnostics (IMDX) and Innovent Biologics (OtherIVBXF)

Insight Molecular Diagn Price Target Maintained with a $9.00/Share by Needham

Insight Molecular Diagnostics Gelar Acara Virtual KOL Bahas Uji Penolakan Transplantasi Jantung Berbasis GraftAssure

Insight Molecular Diagnostics (IMDX) Receives a Buy from Lake Street

Michael Matson Reiterates Buy on IMDX, Citing Regulatory Progress, GraftAssure Platform Expansion, and Solid Cash Runway Ahead of Expected 2026 De Novo Approval

Insight Molecular Diagnostics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Insight Molecular Diagnostics Q2 FY26 Net Loss Widens to $11.26 Million; Revenue Falls to $239,000

Insight Molecular Q2 Adj. EPS $(0.31) Misses $(0.24) Estimate, Sales $239.000K Miss $437.500K Estimate

Benzinga Earnings

Imdx Reports Second Quarter 2026 Results and Timely Progress on FDA Review of Graftassuredx

THOMSON REUTERS

Insight Molecular Diagnostics Inc Expected to Post a Loss of 24 Cents a Share - Earnings Preview

Insight Molecular Diagnostics Updates Financial Calendar Ahead of Quarterly Results Webinar

GALACTIC Trial: IMDX Advances Non‑Invasive Kidney Transplant Monitoring

Insight Molecular Diagnostics highlights Lancet study on GraftAssure assay

iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant

Insight Molecular Diagnostics shareholders approve 1,750,000-share increase to equity plan

Insight Molecular Diagnostics says Clinical Chemistry study shows 99.2% agreement between GraftAssure and rival NGS dd-cfDNA test at 0.5% threshold

Insight Molecular Diagnostics says study shows GraftAssure CM-Score lifts kidney transplant rejection PPV to 81%

Insight Molecular Diagnostics to showcase GraftAssure at American Transplant Congress

iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IMDX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDX\",,,,,undefined,":{"symbol":"IMDX","market":"US","secType":"STK","nameCN":"Insight Molecular Diagnostics Inc.","latestPrice":4.33,"timestamp":1787586449008,"preClose":4.34,"halted":0,"volume":21127,"delay":0,"changeRate":-0.002304147465437739,"floatShares":10405400,"shares":32724284,"eps":-1.463822,"marketStatus":"Trading","change":-0.01,"latestTime":"08-24 11:48:20 EDT","open":4.37,"high":4.4626,"low":4.23,"amount":91044.36210609999,"amplitude":0.053594,"askPrice":4.35,"askSize":11,"bidPrice":4.33,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-1.463822,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":4.34,"preHourTrading":{"tag":"盘前","latestPrice":4.36,"preClose":4.34,"latestTime":"09:26 EDT","volume":643,"amount":2880.150034,"timestamp":1787577996909,"change":0.02,"changeRate":0.004608,"amplitude":0.062212},"postHourTrading":{"tag":"盘后","latestPrice":4.34,"preClose":4.34,"latestTime":"16:10 EDT","volume":710,"amount":3081.4,"timestamp":1787343004724,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.415743,"impliedVol":8.3361,"impliedVolPercentile":0.9026},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDX\",,,,,undefined,":{"symbol":"IMDX","floatShares":10405400,"roa":"-57.82%","roe":"-23603.11%","lyrEps":-1.65,"volumeRatio":0.415743,"shares":32724284,"dividePrice":0,"high":4.4626,"amplitude":0.053594,"preClose":4.34,"low":4.23,"week52Low":2.33,"pbRate":"-6.65","psRate":"84.85","week52High":8.51,"institutionHeld":0,"latestPrice":4.33,"committee":-0.833333,"eps":-1.463822,"divideRate":0,"volume":21127,"delay":0,"ttmEps":-1.463822,"open":4.37,"prevYearClose":7.5,"prevWeekClose":4.34,"prevMonthClose":4.65,"prevQuarterClose":5.9,"fiveDayClose":4.27,"twentyDayClose":4.7,"sixtyDayClose":6.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMDX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"IMDX","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2026-05-13","symbol":"IMDX","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2026-03-26","symbol":"IMDX","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2025-11-10","symbol":"IMDX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2025-08-11","symbol":"IMDX","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMDX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMDX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1743220800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMDX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMDX","date":"2026-08-21","current":-2.964841,"percent":0.467577,"low":-4.420615,"twenty":-3.335591,"median":-2.772491,"eighty":-1.488804,"high":-1.083107,"avg":-2.577338,"sd":0.887337,"marketCap":140714421},"quantilePoints":[{"date":"2025-06-20","current":-1.55268,"twenty":-1.55268,"median":-1.55268,"eighty":-1.55268,"marketCap":90373740},{"date":"2025-06-27","current":-1.655864,"twenty":-1.798357,"median":-1.675518,"eighty":-1.638667,"marketCap":96379590},{"date":"2025-07-03","current":-1.40036,"twenty":-1.71581,"median":-1.6055,"eighty":-1.491752,"marketCap":81507962},{"date":"2025-07-11","current":-1.420014,"twenty":-1.663726,"median":-1.493717,"eighty":-1.427876,"marketCap":82651933},{"date":"2025-07-18","current":-1.390533,"twenty":-1.642106,"median":-1.471607,"eighty":-1.399377,"marketCap":80935976},{"date":"2025-07-25","current":-1.454409,"twenty":-1.585601,"median":-1.459323,"eighty":-1.399377,"marketCap":84653883},{"date":"2025-08-01","current":-1.238213,"twenty":-1.556611,"median":-1.424927,"eighty":-1.390533,"marketCap":72070198},{"date":"2025-08-08","current":-1.289805,"twenty":-1.50551,"median":-1.405274,"eighty":-1.357121,"marketCap":75073123},{"date":"2025-08-15","current":-1.083107,"twenty":-1.489787,"median":-1.40036,"eighty":-1.288331,"marketCap":68687397},{"date":"2025-08-22","current":-1.119211,"twenty":-1.488804,"median":-1.395447,"eighty":-1.253936,"marketCap":70976977},{"date":"2025-08-29","current":-1.132749,"twenty":-1.484873,"median":-1.380706,"eighty":-1.161632,"marketCap":71835569},{"date":"2025-09-05","current":-1.114698,"twenty":-1.480942,"median":-1.363484,"eighty":-1.138165,"marketCap":70690780},{"date":"2025-09-12","current":-1.435117,"twenty":-1.467185,"median":-1.353884,"eighty":-1.132749,"marketCap":91010801},{"date":"2025-09-19","current":-1.520863,"twenty":-1.485856,"median":-1.368397,"eighty":-1.138165,"marketCap":96448554},{"date":"2025-09-26","current":-1.47122,"twenty":-1.485856,"median":-1.389987,"eighty":-1.149898,"marketCap":93300381},{"date":"2025-10-03","current":-1.507324,"twenty":-1.490769,"median":-1.392517,"eighty":-1.163437,"marketCap":95589961},{"date":"2025-10-10","current":-1.714919,"twenty":-1.500103,"median":-1.395447,"eighty":-1.171561,"marketCap":108755046},{"date":"2025-10-17","current":-2.087237,"twenty":-1.528084,"median":-1.402817,"eighty":-1.173366,"marketCap":132366339},{"date":"2025-10-24","current":-2.897311,"twenty":-1.598867,"median":-1.417558,"eighty":-1.192321,"marketCap":183738788},{"date":"2025-10-31","current":-2.67392,"twenty":-1.674528,"median":-1.432479,"eighty":-1.204957,"marketCap":169572012},{"date":"2025-11-07","current":-2.933415,"twenty":-1.775372,"median":-1.457682,"eighty":-1.224911,"marketCap":186028368},{"date":"2025-11-14","current":-3.696486,"twenty":-2.084901,"median":-1.473476,"eighty":-1.250005,"marketCap":224665029},{"date":"2025-11-21","current":-2.862765,"twenty":-2.669859,"median":-1.478977,"eighty":-1.260815,"marketCap":173993132},{"date":"2025-11-28","current":-2.895779,"twenty":-2.764631,"median":-1.48389,"eighty":-1.270643,"marketCap":175999643},{"date":"2025-12-05","current":-2.631669,"twenty":-2.764631,"median":-1.488804,"eighty":-1.282435,"marketCap":159947558},{"date":"2025-12-12","current":-2.452451,"twenty":-2.743778,"median":-1.493785,"eighty":-1.285383,"marketCap":149055072},{"date":"2025-12-19","current":-2.447735,"twenty":-2.714849,"median":-1.505068,"eighty":-1.294719,"marketCap":148768428},{"date":"2025-12-26","current":-2.744859,"twenty":-2.739199,"median":-1.51635,"eighty":-1.307003,"marketCap":166827023},{"date":"2026-01-02","current":-3.537189,"twenty":-2.766436,"median":-1.545684,"eighty":-1.326657,"marketCap":214983277},{"date":"2026-01-09","current":-3.537189,"twenty":-2.848616,"median":-1.572334,"eighty":-1.341398,"marketCap":214983277},{"date":"2026-01-16","current":-3.122159,"twenty":-2.895779,"median":-1.658314,"eighty":-1.353884,"marketCap":189758572},{"date":"2026-01-23","current":-3.150456,"twenty":-2.900495,"median":-1.677968,"eighty":-1.357494,"marketCap":191478439},{"date":"2026-01-30","current":-3.122159,"twenty":-2.986727,"median":-1.755536,"eighty":-1.360521,"marketCap":189758572},{"date":"2026-02-06","current":-3.155173,"twenty":-3.018554,"median":-1.819819,"eighty":-1.364943,"marketCap":191765083},{"date":"2026-02-13","current":-2.951395,"twenty":-3.074996,"median":-2.083343,"eighty":-1.369886,"marketCap":179379897},{"date":"2026-02-20","current":-2.87381,"twenty":-3.072166,"median":-2.244936,"eighty":-1.382344,"marketCap":174664420},{"date":"2026-02-27","current":-3.000829,"twenty":-3.054013,"median":-2.378582,"eighty":-1.390315,"marketCap":182384395},{"date":"2026-03-06","current":-2.900272,"twenty":-3.054013,"median":-2.405289,"eighty":-1.390533,"marketCap":176272748},{"date":"2026-03-13","current":-2.588017,"twenty":-3.035708,"median":-2.450093,"eighty":-1.392913,"marketCap":157294478},{"date":"2026-03-20","current":-2.074647,"twenty":-3.019142,"median":-2.42887,"eighty":-1.395068,"marketCap":126092915},{"date":"2026-03-27","current":-2.175204,"twenty":-3.007939,"median":-2.401676,"eighty":-1.395447,"marketCap":132204561},{"date":"2026-04-02","current":-2.203374,"twenty":-3.005074,"median":-2.393547,"eighty":-1.397412,"marketCap":110657844},{"date":"2026-04-10","current":-2.03684,"twenty":-3.002883,"median":-2.367559,"eighty":-1.40036,"marketCap":102294170},{"date":"2026-04-17","current":-2.24821,"twenty":-2.997331,"median":-2.315182,"eighty":-1.402326,"marketCap":112909602},{"date":"2026-04-24","current":-2.254615,"twenty":-2.992083,"median":-2.318101,"eighty":-1.405274,"marketCap":113231282},{"date":"2026-05-01","current":-2.568468,"twenty":-2.989405,"median":-2.378582,"eighty":-1.410188,"marketCap":128993591},{"date":"2026-05-08","current":-3.176958,"twenty":-2.997331,"median":-2.400572,"eighty":-1.41854,"marketCap":159553170},{"date":"2026-05-15","current":-4.332878,"twenty":-3.023006,"median":-2.404034,"eighty":-1.423945,"marketCap":207289210},{"date":"2026-05-22","current":-3.96843,"twenty":-3.074996,"median":-2.408339,"eighty":-1.431951,"marketCap":189853669},{"date":"2026-05-29","current":-4.407117,"twenty":-3.122159,"median":-2.447735,"eighty":-1.438975,"marketCap":210840894},{"date":"2026-06-05","current":-4.420615,"twenty":-3.146683,"median":-2.45635,"eighty":-1.455064,"marketCap":211486655},{"date":"2026-06-12","current":-3.664724,"twenty":-3.159245,"median":-2.45958,"eighty":-1.45801,"marketCap":175324051},{"date":"2026-06-18","current":-3.590484,"twenty":-3.201673,"median":-2.518479,"eighty":-1.459323,"marketCap":171772367},{"date":"2026-06-26","current":-3.772957,"twenty":-3.230633,"median":-2.562063,"eighty":-1.47122,"marketCap":180502033},{"date":"2026-07-02","current":-3.840452,"twenty":-3.255363,"median":-2.59331,"eighty":-1.47483,"marketCap":183731050},{"date":"2026-07-10","current":-3.273496,"twenty":-3.306599,"median":-2.614479,"eighty":-1.477539,"marketCap":156607309},{"date":"2026-07-17","current":-3.179003,"twenty":-3.306599,"median":-2.644897,"eighty":-1.47878,"marketCap":152086686},{"date":"2026-07-24","current":-3.34774,"twenty":-3.348171,"median":-2.67392,"eighty":-1.479992,"marketCap":160159228},{"date":"2026-07-31","current":-3.104759,"twenty":-3.335591,"median":-2.690166,"eighty":-1.482432,"marketCap":148534768},{"date":"2026-08-07","current":-3.239748,"twenty":-3.35124,"median":-2.73071,"eighty":-1.484411,"marketCap":154992801},{"date":"2026-08-14","current":-2.459675,"twenty":-3.348603,"median":-2.744859,"eighty":-1.487186,"marketCap":121407093},{"date":"2026-08-21","current":-2.850836,"twenty":-3.335591,"median":-2.772491,"eighty":-1.488804,"marketCap":140714421}],"updateTime":1787569136943},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMDX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661207622","title":"Insight Molecular Diagnostics initiated with a Buy at Lucid Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2661207622","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661207622?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:15","pubTimestamp":1787566527,"startTime":"0","endTime":"0","summary":"Lucid Capital initiated coverage of Insight Molecular Diagnostics (IMDX) with a Buy rating and $8 price target The company is seeking to compete di...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/insight-molecular-diagnostics-initiated-with-a-buy-at-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/insight-molecular-diagnostics-initiated-with-a-buy-at-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4555","BK4099","BK4551","LCDL","LCID","BK4596","BK4139","LCIZ","IMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660493221","title":"Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), Insight Molecular Diagnostics (IMDX) and Innovent Biologics (OtherIVBXF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660493221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660493221?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:40","pubTimestamp":1787064009,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amylyx Pharmaceuticals Inc (AMLX), Insight Molecular...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amylyx-pharmaceuticals-inc-amlx-insight-molecular-diagnostics-imdx-and-innovent-biologics-otherivbxf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amylyx-pharmaceuticals-inc-amlx-insight-molecular-diagnostics-imdx-and-innovent-biologics-otherivbxf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","XBI","LABU","BK4137","HCSG","BK4581","LU0128526141.USD","XLV","AMLX","LU0029874061.USD","BK4007","IMDX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660690834","title":"Insight Molecular Diagn Price Target Maintained with a $9.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2660690834","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660690834?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:40","pubTimestamp":1787049600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMDX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658438959","title":"Insight Molecular Diagnostics Gelar Acara Virtual KOL Bahas Uji Penolakan Transplantasi Jantung Berbasis GraftAssure","url":"https://stock-news.laohu8.com/highlight/detail?id=2658438959","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658438959?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:12","pubTimestamp":1786479126,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics gelar acara virtual KOL bahas uji penolakan transplantasi jantung berbasis GraftAssureInsight Molecular Diagnostics menjadwalkan acara virtual KOL pada 17 Agustus 2026 pu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL3bhm6C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMDX","SG9999014005.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014021.USD","SG9999014013.SGD","LU2210149790.SGD","BK4585","BK4139","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","NDAQ","BK4082","BCDF","IE00BN0W2W23.USD","SG9999014039.USD","LU2210150020.SGD","BK4588","IE00B3QW5Z07.USD","MDIT","LU0314104364.USD","LU2095319765.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916684","title":"Insight Molecular Diagnostics (IMDX) Receives a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916684","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658916684?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:55","pubTimestamp":1786456520,"startTime":"0","endTime":"0","summary":"Lake Street analyst Thomas Flaten maintained a Buy rating on Insight Molecular Diagnostics today and set a price target of $12.00. Flaten covers th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/insight-molecular-diagnostics-imdx-receives-a-buy-from-lake-street-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/insight-molecular-diagnostics-imdx-receives-a-buy-from-lake-street-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658299687","title":"Michael Matson Reiterates Buy on IMDX, Citing Regulatory Progress, GraftAssure Platform Expansion, and Solid Cash Runway Ahead of Expected 2026 De Novo Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2658299687","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658299687?lang=en_us&edition=fundamental","pubTime":"2026-08-11 17:15","pubTimestamp":1786439729,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Matson from Needham assigned a Buy rating on Insight Molecular Diagnostics, with a price target of $9.00. Micha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/michael-matson-reiterates-buy-on-imdx-citing-regulatory-progress-graftassure-platform-expansion-and-solid-cash-runway-ahead-of-expected-2026-de-novo-approval-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/michael-matson-reiterates-buy-on-imdx-citing-regulatory-progress-graftassure-platform-expansion-and-solid-cash-runway-ahead-of-expected-2026-de-novo-approval-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4021","MATX","IMDX","BK4139","LU2065732104.USD","BK4097","BOAT","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658950789","title":"Insight Molecular Diagnostics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658950789","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658950789?lang=en_us&edition=fundamental","pubTime":"2026-08-11 08:00","pubTimestamp":1786406446,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings SummaryInsight Molecular Diagnostics IncIMDX.OQreported a quarterly adjusted loss of 31 cents per share for t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N448000:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMDX","BK4082","BK4139","MDIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959788","title":"Insight Molecular Diagnostics Q2 FY26 Net Loss Widens to $11.26 Million; Revenue Falls to $239,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959788","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959788?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:18","pubTimestamp":1786393124,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics Q2 FY26 net loss widens to $11.26 million; revenue falls to $239,000Insight Molecular Diagnostics posted Q2 2026 revenue of USD 239,000, down 53.86% from USD 518,000 a ye","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL58TGlz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BCDF","LU2095319765.USD","BK4588","IE00B64PRP62.GBP","MDIT","SG9999014005.SGD","NDAQ","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IMDX","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014039.USD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","SG9999014013.SGD","BK4139","BK4082","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658017956","title":"Insight Molecular Q2 Adj. EPS $(0.31) Misses $(0.24) Estimate, Sales $239.000K Miss $437.500K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658017956","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658017956?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392356,"startTime":"0","endTime":"0","summary":"Insight Molecular (NASDAQ:IMDX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.24) by 29.17 percent. This is a 3.33 percent decrease over losses of $(0.30) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61091091/insight-molecular-q2-adj-eps-0-31-misses-0-24-estimate-sales-239-000k-miss-437-500k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Insight Molecular Q2 Adj. EPS $(0.31) Misses $(0.24) Estimate, Sales $239.000K Miss $437.500K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956775","title":"Imdx Reports Second Quarter 2026 Results and Timely Progress on FDA Review of Graftassuredx","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956775","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956775?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392305,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA5NTT6M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","IMDX","BIO","BK4121","LU1169589451.USD","BK4139","LU1169590202.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657062101","title":"Insight Molecular Diagnostics Inc Expected to Post a Loss of 24 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657062101","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657062101?lang=en_us&edition=fundamental","pubTime":"2026-08-08 07:22","pubTimestamp":1786144925,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics Inc <IMDX.OQ> expected to post a loss of24cents a share - Earnings PreviewInsight Molecular Diagnostics IncIMDX.OQIMDX.Ois expected to  show a fall in quarterly revenue w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4442PX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDIT","IMDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656153019","title":"Insight Molecular Diagnostics Updates Financial Calendar Ahead of Quarterly Results Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2656153019","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656153019?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:04","pubTimestamp":1785841491,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics updates financial calendar ahead of quarterly results webinarInsight Molecular Diagnostics will report Q2 2026 results on Aug. 10, 2026, with a 5 p.m. ET Zoom webcast and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDLNHGtq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","BK4082","BK4112","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4585","BCDF","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014039.USD","SG9999014021.USD","BK4588","IE00B3QW5Z07.USD","NDAQ","LU2210150020.SGD","LU2210149790.SGD","BK4139","IE00BKPKM429.USD","MDIT","LU2095319765.USD","SG9999014005.SGD","IMDX","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655047128","title":"GALACTIC Trial: IMDX Advances Non‑Invasive Kidney Transplant Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2655047128","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655047128?lang=en_us&edition=fundamental","pubTime":"2026-07-31 00:32","pubTimestamp":1785429161,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics Inc. ($IMDX) announced an update on their ongoing clinical study. The GALACTIC Registry Study, led by Insight Molecul...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galactic-trial-imdx-advances-noninvasive-kidney-transplant-monitoring?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galactic-trial-imdx-advances-noninvasive-kidney-transplant-monitoring?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653725344","title":"Insight Molecular Diagnostics highlights Lancet study on GraftAssure assay","url":"https://stock-news.laohu8.com/highlight/detail?id=2653725344","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653725344?lang=en_us&edition=fundamental","pubTime":"2026-07-23 21:30","pubTimestamp":1784813433,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics (IMDX) highlighted the publication of a study in The Lancet Regional Health – Europe, part of the Lancet Group, demon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/insight-molecular-diagnostics-highlights-lancet-study-on-graftassure-assay-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/insight-molecular-diagnostics-highlights-lancet-study-on-graftassure-assay-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645074564","title":"iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant","url":"https://stock-news.laohu8.com/highlight/detail?id=2645074564","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645074564?lang=en_us&edition=fundamental","pubTime":"2026-06-23 02:07","pubTimestamp":1782151620,"startTime":"0","endTime":"0","summary":"-Grant Supports Health Economic Research Comparing In-House versus Send-Out dd-cfDNA Testing in Kidney Transplantation- NASHVILLE, Tenn., June  22, 2026  (GLOBE NEWSWIRE) -- Insight Molecular Diagnost","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/22/3315564/0/en/iMDx-and-the-American-Society-of-Transplant-Surgeons-Announce-Recipients-of-the-ASTS-iMDx-Health-Economics-Research-Grant.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644729120","title":"Insight Molecular Diagnostics shareholders approve 1,750,000-share increase to equity plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2644729120","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644729120?lang=en_us&edition=fundamental","pubTime":"2026-06-18 04:06","pubTimestamp":1781726776,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics held its annual shareholder meeting on June 11, 2026.Shareholders backed an amendment to the 2018 Equity Incentive Plan, adding 1,750,000 shares for equity awards; total authorization rose to 5,550,000 shares.The plan amendment was authorized by shareholders; the filing does not confirm any equity awards have been issued under the expanded share pool.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insight Molecular Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL531xTd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDIT","BK4082","IMDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644767298","title":"Insight Molecular Diagnostics says Clinical Chemistry study shows 99.2% agreement between GraftAssure and rival NGS dd-cfDNA test at 0.5% threshold","url":"https://stock-news.laohu8.com/highlight/detail?id=2644767298","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644767298?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:05","pubTimestamp":1781640355,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics says Clinical Chemistry study shows 99.2% agreement between GraftAssure and rival NGS dd-cfDNA test at 0.5% threshold. Insight Molecular Diagnostics announced a peer-reviewed Clinical Chemistry head-to-head study comparing its GraftAssure transplant test with a competing NGS assay.Results were first presented in 2025 at the European Renal Association and ESOT Congress, with additional data scheduled for the American Transplant Congress on June 20-24, 2026.The study found the two methods produced closely aligned clinical results in kidney transplant recipients, supporting interchangeability for routine rejection-risk monitoring.Digital PCR showed an analytical advantage in detecting very low biomarker levels, which could support earlier intervention and tighter longitudinal monitoring.The publication supports iMDx’s strategy to shift testing into hospital labs using kit-based workflows, targeting faster turnaround times and lower costs versus send-out testi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL8nXhFb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BN0W2W23.USD","BK4588","SG9999014005.SGD","BK4139","SG9999014021.USD","LU0314104364.USD","LU2095319765.USD","MDIT","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","IMDX","LU2210150020.SGD","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","LU2210149790.SGD","BK4082","SG9999014039.USD","NDAQ","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642231769","title":"Insight Molecular Diagnostics says study shows GraftAssure CM-Score lifts kidney transplant rejection PPV to 81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642231769","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642231769?lang=en_us&edition=fundamental","pubTime":"2026-06-12 04:17","pubTimestamp":1781209065,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics announced an American Journal of Transplantation pre-proof supporting its GraftAssure kidney transplant rejection monitoring assay.Results were first presented as a late-breaking report at the World Transplant Congress in August 2025.The analysis found a combined-score approach outperformed single-measure dd-cfDNA methods, improving rule-in confidence while maintaining strong rule-out performance.The dataset included both screening and for-cause testing cohorts, with validation against multiple published cohorts.Management plans to present the findings at the American Transplant Congress on June 20-24, 2026, as it pursues FDA authorization for test kits.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL8qJsQh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","LU2095319765.USD","IE00B64PRP62.GBP","IMDX","IE00BN0W2T93.GBP","LU2210149790.SGD","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BGHQF748.EUR","MDIT","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","SG9999014039.USD","LU2210150020.SGD","BK4082","BK4112","SG9999014005.SGD","BK4585","NDAQ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642492057","title":"Insight Molecular Diagnostics to showcase GraftAssure at American Transplant Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2642492057","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642492057?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:06","pubTimestamp":1781035580,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics will highlight its GraftAssure transplant rejection monitoring technology at the American Transplant Congress in Boston, June 20-24.A private reception with transplant physicians and lab directors is scheduled during the meeting to discuss in-house dd-cfDNA testing.Third-party late-breaking head-to-head data on GraftAssureIQ versus a commercial centralized test is set for presentation June 23.Grant winners for an iMDx-ASTS study on in-house versus centralized testing economics will be announced at the conference.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL7yh4Fx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","BK4585","BK4139","BK4082","SG9999014039.USD","IMDX","MDIT","SG9999014005.SGD","LU2095319765.USD","BK4588","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","NDAQ","LU2210150020.SGD","LU2210149790.SGD","LU0314104364.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642849785","title":"iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2642849785","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642849785?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:05","pubTimestamp":1781035500,"startTime":"0","endTime":"0","summary":"Multiple events and presentations will highlight potential benefits of in-house transplanted-organ-rejection testing, and of GraftAssure technology specificallyMajor transplantation conference in Bost","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/09/3309318/0/en/iMDx-to-Highlight-In-House-Transplant-Testing-Opportunity-and-Host-Key-Opinion-Leaders-at-American-Transplant-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}]}}